MEI Pharma Inc (MEIP)
2.38
+0.02
(+0.85%)
USD |
NASDAQ |
Dec 26, 16:00
2.60
+0.22
(+9.24%)
Pre-Market: 09:01
MEI Pharma Research and Development Expense (Quarterly): 3.163M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Evoke Pharma Inc | 0.0117M |
Revance Therapeutics Inc | 11.38M |
NovaBay Pharmaceuticals Inc | 0.004M |
Palatin Technologies Inc | 5.744M |
iBio Inc | 1.305M |